- Home
- ADPT vs SHOO Comparison
ADPT vs SHOO Comparison
Compare ADPT & SHOO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ADPT
- SHOO
- Stock Information
- Founded
- ADPT 2009
- SHOO 1990
- Country
- ADPT United States
- SHOO United States
- Employees
- ADPT N/A
- SHOO N/A
- Industry
- ADPT Biotechnology: Biological Products (No Diagnostic Substances)
- SHOO Shoe Manufacturing
- Sector
- ADPT Health Care
- SHOO Consumer Discretionary
- Exchange
- ADPT Nasdaq
- SHOO Nasdaq
- Market Cap
- ADPT 1.8B
- SHOO 2.0B
- IPO Year
- ADPT 2019
- SHOO 1993
- Fundamental
- Price
- ADPT $12.61
- SHOO $31.15
- Analyst Decision
- ADPT Strong Buy
- SHOO Hold
- Analyst Count
- ADPT 8
- SHOO 7
- Target Price
- ADPT $12.38
- SHOO $27.83
- AVG Volume (30 Days)
- ADPT 1.8M
- SHOO 1.4M
- Earning Date
- ADPT 11-06-2025
- SHOO 11-06-2025
- Dividend Yield
- ADPT N/A
- SHOO 2.70%
- EPS Growth
- ADPT N/A
- SHOO N/A
- EPS
- ADPT N/A
- SHOO 1.28
- Revenue
- ADPT $205,216,000.00
- SHOO $2,319,527,000.00
- Revenue This Year
- ADPT $32.76
- SHOO $11.61
- Revenue Next Year
- ADPT $15.81
- SHOO $10.13
- P/E Ratio
- ADPT N/A
- SHOO $24.42
- Revenue Growth
- ADPT 21.60
- SHOO 7.97
- 52 Week Low
- ADPT $3.98
- SHOO $19.05
- 52 Week High
- ADPT $13.68
- SHOO $50.01
- Technical
- Relative Strength Index (RSI)
- ADPT 51.14
- SHOO 67.10
- Support Level
- ADPT $12.34
- SHOO $29.70
- Resistance Level
- ADPT $13.68
- SHOO $31.90
- Average True Range (ATR)
- ADPT 0.56
- SHOO 1.00
- MACD
- ADPT -0.08
- SHOO 0.17
- Stochastic Oscillator
- ADPT 20.15
- SHOO 81.88
About ADPT Adaptive Biotechnologies Corporation
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is test authorized by the FDA for the detection and monitoring of minimal residual disease (MRD) in patients with multiple myeloma (MM), B cell acute lymphoblastic leukemia (ALL) and chronic lymphocytic leukemia (CLL) and is also available as a CLIA-validated laboratory developed test (LDT) for patients with other lymphoid cancers, including diffuse large B-cell lymphoma (DLBCL).
About SHOO Steven Madden Ltd.
Steven Madden Ltd designs and sells brand-name and private-label footwear and accessories. Its products are geared toward fashion-conscious adults and children. The company sells its products through department stores and other retailers as well as its stores and websites. The company's revenue comes from its operating segments: Wholesale Footwear, Wholesale Accessories or Apparel, Direct-to-Consumer, and Licensing. The wholesale footwear segment accounts for the majority of revenue.